Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Merit Medical Systems Inc., 3 years.
Merit Medical Systems Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 18, 2026 | Merit Medical Systems Inc. | Grant or award | +3,457 | — | — |
| May 15, 2025 | Merit Medical Systems Inc. | Grant or award | +2,152 | — | — |
| May 15, 2025 | Merit Medical Systems Inc. | Option exercise | +21,250 | $52.17 | $1,108,613 |
| May 15, 2025 | Merit Medical Systems Inc. | Open-market sale | −21,250 | $96.47 | $2,049,988 |
| Nov 15, 2024 | Merit Medical Systems Inc. | Option exercise | +12,500 | $50.50 | $631,250 |
| Nov 15, 2024 | Merit Medical Systems Inc. | Open-market sale | −12,500 | $101.55 | $1,269,375 |
| Jun 28, 2024 | Merit Medical Systems Inc. | Option exercise | +12,500 | $50.50 | $631,250 |
| Jun 28, 2024 | Merit Medical Systems Inc. | Open-market sale | −12,299 | $85.00 | $1,045,415 |
| Jun 28, 2024 | Merit Medical Systems Inc. | Open-market sale | −201 | $85.00 | $17,085 |
| May 16, 2024 | Merit Medical Systems Inc. | Grant or award | +2,431 | — | — |
| Jan 22, 2024 | Merit Medical Systems Inc. | Option exercise | +20,000 | $34.40 | $688,000 |
| Jan 22, 2024 | Merit Medical Systems Inc. | Open-market sale | −20,000 | $80.00 | $1,600,000 |
| May 18, 2023 | Merit Medical Systems Inc. | Grant or award | +2,262 | — | — |
Questions about F. Ann Millner
What boards is F. Ann Millner on?
F. Ann Millner sits on the board of Merit Medical Systems Inc.
How long has F. Ann Millner served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.